2024 annual financial data

CollPlant Biotechnologies 2024 Net margin

Direct answer

Net margin was -3,225.05%.

Operating income was -17,251,000 USD and net income was -16,609,000 USD.
Operating cash flow was -14,093,000 USD.

Get free CollPlant Biotechnologies email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
515,000 USD
Operating income
-17,251,000 USD
Net income
-16,609,000 USD
Operating cash flow
-14,093,000 USD